Nom du produit:4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine
IUPAC Name:4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine
- CAS:42754-96-1
- Formule moléculaire:C5H2Cl2N4
- Pureté:95%+
- Numéro de catalogue:CM104106
- Poids moléculaire:189
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:42754-96-1
- Formule moléculaire:C5H2Cl2N4
- Point de fusion:-
- Code SMILES:ClC1=NC(Cl)=C2C=NNC2=N1
- Densité:
- Numéro de catalogue:CM104106
- Poids moléculaire:189
- Point d'ébullition:
- N° Mdl:MFCD09835493
- Stockage:Keep in inert atmosphere, store at 2-8°C.
Category Infos
- Pyrazolopyrimidines
- Pyrazolopyrimidine scaffolds are one of the most important heterocyclic compounds in drug discovery. This scaffold has various biological activities, among which anticancer is an important one.
Column Infos
- ORIC-533
- ORIC-533 is a potential best-in-class, oral inhibitor of CD73 developed by ORIC Pharmaceuticals which is currently in a Ph. Ib trial for the treatment of relapsed/refractory multiple myeloma (MM). It inhibits the CD73-mediated conversion of AMP to adenosine which generates an immunosuppressive tumor microenvironment and has the potential to be a next-generation immunotherapy. The in-depth use of co-crystal structures led the team to discover a novel set of phosphonate bioisosteres which were able to achieve bioavailability for a highly polar scaffold. The structure and discovery story of ORIC-533 were recently presented at the ACS Spring 2024 Meeting in New Orleans.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.